The first United Therapeutics trade was made in Q1 2017.
Since then Jeremy Grantham bought shares five more times and sold shares on seven occasions. The investor completely sold their stake between Q4 2020 and Q3 2021.
Avg closing price
Price range
Sold -2.07 Thousand shares
Q3 2021
Avg closing price
$196.97
Price range
$179.86
-
$214.88
Sold 66.1% shares (-4.04 Thousand shares)
Q2 2021
Avg closing price
$190.45
Price range
$170.47
-
$211.93
Sold 59.8% shares (-9.1 Thousand shares)
Q1 2021
Avg closing price
$166.73
Price range
$153.94
-
$174.85
Sold 61.9% shares (-24.7 Thousand shares)
Q4 2020
Avg closing price
$131.23
Price range
$101.87
-
$151.79
Increased shares by 576.4% (+34 Thousand shares)
Q3 2020
Avg closing price
$109.72
Price range
$99.90
-
$121.13
Sold 28.9% shares (-2.4 Thousand shares)
Q2 2020
Avg closing price
$112.52
Price range
$92.74
-
$125.82
New holding (+8.3 Thousand shares)
Q1 2020
Avg closing price
$95.05
Price range
$79.39
-
$115.35
Sold -5.7 Thousand shares
Q2 2019
Avg closing price
$93.51
Price range
$76.06
-
$120.81
Sold 8.1% shares (-500 shares)
Q1 2019
Avg closing price
$116.52
Price range
$107.15
-
$126.84
Increased shares by 3.3% (+200 shares)
Q2 2018
Avg closing price
$109.92
Price range
$101.14
-
$118.31
Increased shares by 150.0% (+3.6 Thousand shares)
Q1 2018